These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17495932)

  • 1. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.
    Kaiser BK; Yim D; Chow IT; Gonzalez S; Dai Z; Mann HH; Strong RK; Groh V; Spies T
    Nature; 2007 May; 447(7143):482-6. PubMed ID: 17495932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.
    Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z
    Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
    Waldhauer I; Steinle A
    Cancer Res; 2006 Mar; 66(5):2520-6. PubMed ID: 16510567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H; Kim J; Cosman D; Choi I
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.
    Li P; Morris DL; Willcox BE; Steinle A; Spies T; Strong RK
    Nat Immunol; 2001 May; 2(5):443-51. PubMed ID: 11323699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.
    Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA
    J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
    Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
    J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.
    Salih HR; Goehlsdorf D; Steinle A
    Hum Immunol; 2006 Mar; 67(3):188-95. PubMed ID: 16698441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D and Related Immunoreceptors.
    Strong RK; McFarland BJ
    Adv Protein Chem; 2004; 68():281-312. PubMed ID: 15500864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP9 mediates MICA shedding in human osteosarcomas.
    Sun D; Wang X; Zhang H; Deng L; Zhang Y
    Cell Biol Int; 2011 Jun; 35(6):569-74. PubMed ID: 21143201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
    Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D
    Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
    Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.
    Chalupny NJ; Rein-Weston A; Dosch S; Cosman D
    Biochem Biophys Res Commun; 2006 Jul; 346(1):175-81. PubMed ID: 16750166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.
    Maccalli C; Pende D; Castelli C; Mingari MC; Robbins PF; Parmiani G
    Eur J Immunol; 2003 Jul; 33(7):2033-43. PubMed ID: 12884870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated MICA is shed by ADAM proteases.
    Waldhauer I; Goehlsdorf D; Gieseke F; Weinschenk T; Wittenbrink M; Ludwig A; Stevanovic S; Rammensee HG; Steinle A
    Cancer Res; 2008 Aug; 68(15):6368-76. PubMed ID: 18676862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
    Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
    J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
    Zwirner NW; Fuertes MB; Girart MV; Domaica CI; Rossi LE
    Cytokine Growth Factor Rev; 2007; 18(1-2):159-70. PubMed ID: 17324607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes and the MICA-NKG2D system in cancer.
    Clayton A; Tabi Z
    Blood Cells Mol Dis; 2005; 34(3):206-13. PubMed ID: 15885603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.